UVA Health Study Links Race to Asthma Inflammation
Researchers found Black children face a higher risk of T2 inflammation in severe asthma cases.
Updated on Oct. 15, 2026 in Asthma
Live Poll
Should medical treatments be more specifically tailored based on a patient's demographic and biological risk factors?
UVA Health Childrens researchers identified that Black race and ethnicity are the strongest predictors of elevated T2 inflammation in children with severe asthma. The findings emerged from a study of 451 Virginia children conducted to determine if inflammation disparities persist after accounting for social and environmental factors.
Why it matters
Understanding the prevalence of T2-high asthma in specific populations helps physicians recognize the need for earlier testing. These findings may enable more targeted treatment strategies for young patients at higher risk of severe inflammation.
Researchers studied 451 children, finding that over 33% developed T2-high asthma by preschool and over 50% by kindergarten. Black race and ethnicity remained the strongest predictor of elevated inflammation despite controlling for environmental and social data.
The players
UVA Health Childrens
This pediatric healthcare organization based in Charlottesville provides comprehensive medical services and conducts clinical research.
The Journal of Allergy and Clinical Immunology: In Practice
This peer-reviewed medical journal publishes research focused on allergic and immunologic diseases and clinical practice.
The details
The analysis accounted for variables including residential location, family income, and air quality to isolate the role of race. Researchers compared cohorts of children with T2-high and T2-low asthma to assess the factors driving these inflammation markers.
Timeline
October 15, 2026: Research findings were officially published.
Health Landscape
This research builds upon existing knowledge of health disparities by highlighting specific immunological differences in pediatric asthma. It advances the medical communitys ability to identify high-risk phenotypes that persist across diverse socioeconomic backgrounds.
These findings suggest that pediatricians may need to prioritize earlier inflammation testing for children who fit higher-risk profiles. Parents should discuss asthma management and potential T2-high markers with their primary care physician to ensure the most effective treatment plan.
The takeaway
Early identification of specific asthma phenotypes is crucial for preventing severe outcomes in children. Clinicians are encouraged to look beyond environmental factors when evaluating inflammation risks in pediatric patients.
Further reading
For additional context on respiratory conditions, visit the Asthma section.
More information
View the full Published study00554-1/fulltext) for complete methodology and results.
Source note: This article includes information reported by 29news.
Live Poll
Should medical treatments be more specifically tailored based on a patient's demographic and biological risk factors?
